Question 1

What is LEDIPASVIR AND SOFOSBUVIR used for?

Accepted Answer

LEDIPASVIR AND SOFOSBUVIR (brand name Ledipasvir and Sofosbuvir) is a Other indicated for or 6 infection without cirrhosis or with compensated cirrhosis genotype 1 infection with decompensated cirrhosis, for use in combination with ribavirin genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, for use in combination with ribavirin Ledipasvir and sofosbuvir is a fixed-dose combination of ledipasvir.

Question 2

How does LEDIPASVIR AND SOFOSBUVIR work?

Accepted Answer

LEDIPASVIR AND SOFOSBUVIR works through the following mechanism: 12.1 Mechanism of Action Ledipasvir and sofosbuvir tablets (90 mg/400 mg) are a fixed-dose combination of ledipasvir and sofosbuvir, which are direct-acting antiviral agents against the hepatitis C virus [see Microbiology (12.4) ]..

Question 3

What are the most common side effects of LEDIPASVIR AND SOFOSBUVIR?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for LEDIPASVIR AND SOFOSBUVIR. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is LEDIPASVIR AND SOFOSBUVIR the same as Ledipasvir and Sofosbuvir?

Accepted Answer

Ledipasvir and Sofosbuvir is a brand name for LEDIPASVIR AND SOFOSBUVIR. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

LEDIPASVIR AND SOFOSBUVIR

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations